Bloomberg Markets: Abercrombie & Fitch Plunges, Coke Endowments

Bloomberg Markets: Abercrombie & Fitch Plunge...

Up next

Cathie Wood Unveils ARK Invest's Big Ideas for 2026

ARK Invest’s "Big Ideas 2026" marks the 10th annual edition of the firm's flagship research report. ARK says the report is designed to identify and contextualize the technologies reshaping the global economy. The company aims to find key signals and focus on long-term innovation ...  Show more

Intel Gives Weak Forecast After Supply Shortages Hurt Sales

Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF. Intel Corp. gave a lackluster forecast for the current quarter because supply shortages are making it harder to meet customer demand, a disappointment for investors who anticipated more of a boost from new prod ...  Show more

Recommended Episodes

Michael Bloomberg's Dark And Terrible Life Story
Worst Year Ever

Robert, Katy, and Cody discuss former New York Mayor and presidential candidate, Michael Bloomberg. Best Bloomberg Ever! Learn more about your ad-choices at https://www.iheartpodcastnetwork.comSee omnystudio.com/listener for privacy information. 

BONUS EPISODE: Bloomberg Surveillance in Jackson Hole
Odd Lots

Bloomberg Surveillance comes to the Odd Lots podcast!  Listen for a special edition of Bloomberg Surveillance from the Federal Reserve's annual symposium in Jackson Hole, Wyoming.  Hear more from Bloomberg Surveillance on Apple or Spotify. Guests in this episode: Mohamed El-Erian ...  Show more

Bloomberg Wall Street Week: May 27th, 2022
Wall Street Week

One of the most iconic brands in financial television returns for today's issues and today's world. On this edition of Wall Street Week, Liz Ann Sonders, Charles Schwab Chief Investment Strategist & Ben Inker, GMO Co-Head of Asset Allocation wrap up a volatile week in the markets ...  Show more

Bloomberg Surveillance: Bloomberg BNA's Eleanor Tyler on pharma
Bloomberg Surveillance

Bloomberg BNA's Eleanor Tyler joins Tom Keene and Mike McKee to discuss pharmaceutical mergeres, tax inversions, drug pricing, and the renewed efforts by the Federal Trade Commission to regulate an increasingly complicated industry. Learn more about your ad-choices at https://www ...  Show more